Hastings, C. A. Et Al. 2024. Transport^®NPC: open phase 3 global trial of intravenous hydroxypropyl-beta-cyclodextrin in patients with Niemann-Pick disease type C1 (NPC1). 20th Annual World Symposium , (California, United States Of America).

Hastings, C. A., Goker-Alpan, O., Pena, L., Bayarri, J. G., Martin-Hernandez, E., Sharma, R., ... Chacham, O. S.(2024). Transport^®NPC: open phase 3 global trial of intravenous hydroxypropyl-beta-cyclodextrin in patients with Niemann-Pick disease type C1 (NPC1) . 20th Annual World Symposium, California, United States Of America

Hastings, Caroline Et Al. "Transport^®NPC: open phase 3 global trial of intravenous hydroxypropyl-beta-cyclodextrin in patients with Niemann-Pick disease type C1 (NPC1)," 20th Annual World Symposium, California, United States Of America, 2024

Hastings, Caroline A. Et Al. "Transport^®NPC: open phase 3 global trial of intravenous hydroxypropyl-beta-cyclodextrin in patients with Niemann-Pick disease type C1 (NPC1)." 20th Annual World Symposium , California, United States Of America, 2024

Hastings, C. A. Et Al. (2024) . "Transport^®NPC: open phase 3 global trial of intravenous hydroxypropyl-beta-cyclodextrin in patients with Niemann-Pick disease type C1 (NPC1)." 20th Annual World Symposium , California, United States Of America.

@conferencepaper{conferencepaper, author={Caroline A. Hastings Et Al. }, title={Transport^®NPC: open phase 3 global trial of intravenous hydroxypropyl-beta-cyclodextrin in patients with Niemann-Pick disease type C1 (NPC1)}, congress name={20th Annual World Symposium}, city={California}, country={United States Of America}, year={2024}}